BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21158752)

  • 1. Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis.
    McDonald J; Damjanovich K; Millson A; Wooderchak W; Chibuk JM; Stevenson DA; Gedge F; Bayrak-Toydemir P
    Clin Genet; 2011 Apr; 79(4):335-44. PubMed ID: 21158752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
    Bossler AD; Richards J; George C; Godmilow L; Ganguly A
    Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
    Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P
    J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
    Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
    Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
    Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
    Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in the ENG and ACVRL1 genes causing hereditary hemorrhagic teleangiectasia.
    Argyriou L; Twelkemeyer S; Panchulidze I; Wehner LE; Teske U; Engel W; Nayernia K
    Int J Mol Med; 2006 Apr; 17(4):655-9. PubMed ID: 16525724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
    Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
    Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique.
    Sadick H; Hage J; Goessler U; Stern-Straeter J; Riedel F; Hoermann K; Bugert P
    BMC Med Genet; 2009 Jun; 10():53. PubMed ID: 19508727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia.
    Abdalla SA; Cymerman U; Rushlow D; Chen N; Stoeber GP; Lemire EG; Letarte M
    Hum Mutat; 2005 Mar; 25(3):320-1. PubMed ID: 15712271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.
    Wooderchak W; Gedge F; McDonald M; Krautscheid P; Wang X; Malkiewicz J; Bukjiok CJ; Lewis T; Bayrak-Toydemir P
    Clin Genet; 2010 Nov; 78(5):484-9. PubMed ID: 20412114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on molecular diagnosis of hereditary hemorrhagic telangiectasia.
    Richards-Yutz J; Grant K; Chao EC; Walther SE; Ganguly A
    Hum Genet; 2010 Jul; 128(1):61-77. PubMed ID: 20414677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.
    Schulte C; Geisthoff U; Lux A; Kupka S; Zenner HP; Blin N; Pfister M
    Hum Mutat; 2005 Jun; 25(6):595. PubMed ID: 15880681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.
    Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M
    Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
    Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
    BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.
    Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS
    J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel endoglin mutation in hereditary hemorrhagic telangiectasia type 1: a case report.
    Lu Y; Zhu Y; Shi L; Zhen H; Sun Z; Cheng L
    Mol Med Rep; 2015 Jul; 12(1):510-2. PubMed ID: 25760803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
    Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia.
    Lee NP; Matevski D; Dumitru D; Piovesan B; Rushlow D; Gallie BL
    J Med Genet; 2011 May; 48(5):353-7. PubMed ID: 21415079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.